Literature DB >> 16204020

Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting.

Richard M Peek1, Suresh Mohla, Raymond N DuBois.   

Abstract

The Inflammation and Cancer Think Tank Meeting was organized by the National Cancer Institute with the purpose of identifying research advances, gaps, and opportunities for the study and clinical application of the role of inflammation on tumorigenesis. The format of this meeting consisted of brief presentations that focused on concepts, with extensive discussion periods to allow participants to identify issues and barriers limiting progress in this area. The strong relationship between inflammation and cancer in the gastrointestinal tract prompted several presentations that were focused on carcinogenesis within this organ system; however, many of the same immune mediators that influence esophageal, gastric, and colorectal carcinoma were also shown to influence inflammation-related malignancies at other anatomic sites. This article summarizes the findings of this Think Tank Meeting, which highlight the intimate relationship between malignant cells and their inflammatory microenvironment and specifically address opportunities to manipulate the host immune response and therefore intervene at different points along the tumorigenic cascade.

Entities:  

Mesh:

Year:  2005        PMID: 16204020     DOI: 10.1158/0008-5472.CAN-05-1777

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Authors:  G C Prendergast; M Y Chang; L Mandik-Nayak; R Metz; A J Muller
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion.

Authors:  Alexander J Muller; James B DuHadaway; Mee Young Chang; Arivudinambi Ramalingam; Erika Sutanto-Ward; Janette Boulden; Alejandro P Soler; Laura Mandik-Nayak; Susan K Gilmour; George C Prendergast
Journal:  Cancer Immunol Immunother       Date:  2010-07-17       Impact factor: 6.968

3.  Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase.

Authors:  Maria Winters; James B DuHadaway; Khoa N Pham; Ariel Lewis-Ballester; Shorouk Badir; Jenny Wai; Eesha Sheikh; Syun-Ru Yeh; George C Prendergast; Alexander J Muller; William P Malachowski
Journal:  Eur J Med Chem       Date:  2018-11-14       Impact factor: 6.514

4.  Microbial diversity in saliva of oral squamous cell carcinoma.

Authors:  Smruti Pushalkar; Shrinivasrao P Mane; Xiaojie Ji; Yihong Li; Clive Evans; Oswald R Crasta; Douglas Morse; Robert Meagher; Anup Singh; Deepak Saxena
Journal:  FEMS Immunol Med Microbiol       Date:  2011-02-01

5.  Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

Authors:  Alexander J Muller; Madhav D Sharma; Phillip R Chandler; James B Duhadaway; Mary E Everhart; Burles A Johnson; David J Kahler; Jeanene Pihkala; Alejandro Peralta Soler; David H Munn; George C Prendergast; Andrew L Mellor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

6.  Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.

Authors:  Michelle K McHugh; Matthew B Schabath; Chung-Han Ho; Mei Liu; Anthony M D'Amelio; Anthony J Greisinger; George L Delclos; Margaret R Spitz; Carol J Etzel
Journal:  J Immigr Minor Health       Date:  2013-10

7.  Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer.

Authors:  Tracy M Covey; Kornelia Edes; Gary S Coombs; David M Virshup; Frank A Fitzpatrick
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

Review 8.  A review of the application of inflammatory biomarkers in epidemiologic cancer research.

Authors:  Darren R Brenner; Dominique Scherer; Kenneth Muir; Joellen Schildkraut; Paolo Boffetta; Margaret R Spitz; Loic Le Marchand; Andrew T Chan; Ellen L Goode; Cornelia M Ulrich; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254

9.  Individual differences in pre-carcinogen cytokine and corticosterone concentrations and depressive-like behavior predict tumor onset in rats exposed to a carcinogen.

Authors:  Leah M Pyter; Brian J Prendergast
Journal:  Psychoneuroendocrinology       Date:  2012-10-06       Impact factor: 4.905

10.  Correlated alterations in prostate basal cell layer and basement membrane.

Authors:  Aijun Liu; Lixin Wei; William A Gardner; Chu-Xia Deng; Yan-Gao Man
Journal:  Int J Biol Sci       Date:  2009-03-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.